Clinical Trial Update: A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma [Phase 2]

View source ↗

Summary

A multicenter, randomized, double-blind Phase 2 trial evaluated itraconazole oral solution (cyclodextrin formulation) versus placebo for aspergilloma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Pulmonary Aspergilloma

Drugs mentioned

• Itraconazole (oral solution with cyclodextrin formulation) (itraconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Aspergillosis, Lung Diseases, Fungal | Phase 2 | Status: COMPLETED